The antifungal activities of FK463 against various pathogenic fungi were tested by standard broth microdilution methods, and compared with the activities of five currently glabrata), as well as all species of Aspergillus, Paecilomyces and Penicillium, were highly susceptible with GM-MICsof^0.008 /ug/ml The other fungal species including several nonalbicans Candida were less susceptible with GM-MICsranging between 0.016 and 2^g/ml. MICsof the reference drugs were within the range thus previously reported. These results suggest that FK463 be of use in the treatment of serious fungal infections. 
and flucytosine.
Fourteen clinical isolates of Candida albicans categorized as FLCZ susceptible, FLCZsusceptible-dose dependent and FLCZresistant were similarly susceptible to FK463 with geometric (GM) MIC values of 0.010, 0.01 1 and 0.015 jug/ml, respectively.
All of 17 clinical isolates ofAspergillusfumigatus
were inhibited by FK463 at 0.0078 /xg/ml or lower concentrations. The antifungal activity of FK463 against a wider range of medically important yeasts and filamentous fungi were studied using stock fungal strains. While Cryptococcus, Trichosporon, Fusarium, Pseudallescheria and Alternaria species or zygomycetes were scarcely or not inhibited by 16^g/ml of FK463, two Candida species (C. albicans, C.
glabrata), as well as all species of Aspergillus, Paecilomyces and Penicillium, were highly susceptible with GM-MICsof^0.008 /ug/ml The other fungal species including several nonalbicans Candida were less susceptible with GM-MICsranging between 0.016 and 2^g/ml. MICsof the reference drugs were within the range thus previously reported. These results suggest that FK463 be of use in the treatment of serious fungal infections. 
MIC Determination for Filamentous Fungi
Two related antifimgal susceptibility testing methods for filamentous fungi were used: one was the NCCLSM38-P method6) and the other the JSMMmethod for filamentous fungi7).
MICs for filamentous fungi were measured by a broth microdilution method using RPMI1640 medium buffered with 0.165 m MOPSaccording to the standard antifungal VOL.53 NO. 10 THE JOURNAL OF ANTIBIOTICS susceptibility testing method for filamentous fungi by JSMM. In the latter method, a test fungus was cultured on a potato dextrose agar slant at 27°C for 2 to 7 days. Next, a conidial suspension was prepared for the matured cultures by the conventional method using physiological saline supplemented with 0.05% Tween 80. The conidial concentration was enumerated using a hemocytometer. The suspension was adjusted to a conidial concentration of L2X 104cells/ml with RPMI 1640 medium, and was used a$ the inoculum.
A microplate containing frozen drug solutions and the freeze was thawed at ambient temperature. Eighty ji\ of the inoculum together with 20 ji\ of a redox indicator, Alamar Blueá" (Alamar Bioscience Inc.) solution, were dispensed into each well of the microplate. A growth control and negative control were included, and the plate was incubated at 30°C. Results were read when the color of the growth control had changed to a definite red. The end-point was determined visually as the lowest concentration at which the blue color just turned reddish, or by measurement using and that of R isolates (GM-MIC, 107.60/ig/ml) decreased by 24 and 82 times, respectively, as compared with that of S isolates (GM-MIC, 1.32^g/ml). Partly consistent with this, the susceptibility to other azoles, ITCZ and MCZ,of S, SDDand R isolates also decreased in this order. In contrast, these three categories of isolates showed virtually the same susceptibility to AMPHand 5FC. FK463 was highly active against all of S, S-DD and R isolates and its GM-MICsfor them were 0.010, 0.01 1 and 0.015 ug/ml, respectively.
Activity of FK463 and Reference Drugs Against
Clinical Isolates ofA. fumigatus ascomycetous and related imperfect yeast were distributed within a low and narrow concentration range of^0.0078 to 0.25^g/ml, except one strain each of C. krusei, C. parapsilosis and C. guilliermondii with relatively high MIC (>4, 2 and 1 ,ug/ml, respectively).
The MIC range of FK463 for every ascomycetous or related imperfect yeast was at the lowest level among the 6 tested drugs. On the other hand, FK463 had no activity against the basidiomycetous yeast species such as Cryptococcus species and Trichosporon asahii. (3) C. dubliniensis
(1) C. glabrata (3) C. guilliermondii (3) C. inconspicua ( 1) C. krusei (3) C. lambica (1) C lusitaniae (3) C. parapsilosis (3) C. tropicalis (3) C. Kf//« (1) C. zeylanoides (1) Pichia anomala (3) A. niger (3) A. terreus (3) A. clavatus (1) A.japonicus (1) A. nidulans (1) A. oryzae (1) A. versicolor (1) Paecilomyces lilacinus (2) P. variotii (2) Penicillium citeoviride ( 1 ) P. decumbens (1) P. expansion (1) /\ marneffei (3) P. notatum (1 It was demonstrated that with a given fungal strain, both the NCCLSand JSMMmethods gave virtually the identical MIC value for FK463 and were equally satisfactory for its MICdetermination. However, since the JSMMmethod is easier to use to determine simultaneously a large numberof fungal strains with diverse growth rates than is the NCCLS OCT. 2000 method, the former was adopted in subsequent experiments. potency of FK463against susceptible fungal species was greater than any of the reference drugs. These results also show that the antifungal spectrum of FK463is broader than that for 5FC and FLCZ, although it may be inferior to ITCZ, MCZand AMPH. As reported previously1^the high susceptibility to FK463 of FLCZ-resistant isolates of C. albicans was confirmed in the present study. The efficacy of FK463 in treating candidiasis caused by FLCZ-resistant C. albicans and non-albicans Candida, aspergillosis and several other opportunistic or endemic fungal infections due to FK463 susceptible fungi is expected to be a focus of attention in the future.
